"No Gaza genocide links in our NHS": Organisations urge NHS England to end £330m Palantir contract

Amnesty International UK, alongside Medact and Healthcare Workers for a Free Palestine, are calling on NHS England to terminate its £330 million contract with the US software company Palantir Technologies, arguing that companies accused of contributing to serious human rights violations in occupied Gaza should not be embedded within England’s health system.

The groups say the NHS should not partner with companies providing technology to support Israel’s military assaults in Gaza and are urging NHS England to end the contract at or before its review date in February 2027.

In January 2024, Palantir announced a partnership with the Israeli Ministry of Defence to deploy its technology in support of “war-related missions”. The company’s systems are being used in Gaza, where Israeli forces stand accused by human rights organisations and UN experts of genocide and other grave violations of international law.

Kerry Moscogiuri, Chief Executive of Amnesty International UK, said:

“The NHS constitution states that it belongs to the people, underpinned by core values of compassionate care, dignity and humanity. Those principles must apply not only to doctors and nurses, but also to the companies the NHS chooses to contract with using taxpayers' money.

“Any company contributing to human rights violations should have no place at the heart of our NHS. Our message is simple: no Gaza genocide links in our NHS.”

Dr Rhiannon Mihranian Osborne, health worker at Medact, said:

“As health workers we are guided by a simple principle: first, do no harm. That ethical duty should extend to NHS procurement. Public health institutions should not partner with companies whose technology is proudly used to support genocide.”

Local pressure campaign: ‘No Palantir in our NHS’

Amnesty International UK is mobilising activists across England to campaign for their local NHS Trusts and Integrated Care Boards (ICBs) to refuse to use Palantir’s technology due to its connection to global human rights violations.

Amnesty activists will be building local campaigns and joining those already underway across the country, led and supported by Medact and Healthworkers for a Free Palestine.

Palantir’s Federated Data Platform relies on voluntary adoption by individual NHS trusts and ICBs, campaigners believe sustained local pressure could force a national reconsideration of Palantir's contract with NHS England.

Core demands

Amnesty UK is calling on all UK public bodies to responsibly divest and cease purchasing from Palantir, given its links to human rights violations, including Israel’s ongoing genocide against Palestinians. This starts with the 'No Palantir in our NHS' campaign, which focuses on NHS England terminating its contract with Palantir, which is up for review in February 2027.

The groups are calling on the UK government to:

1. Terminate Palantir’s £330 million NHS contract at or before its review date in February 2027.
2. Responsibly divest public sector institutions from Palantir, ending the use of public funds to contract the company.
3. Introduce binding ethical standards for public sector technology procurement, ensuring the NHS cannot partner with companies linked to crimes under international law.

Campaigners say the NHS should lead globally in setting ethical standards for public technology partnerships.

Palantir building the NHS’s data platform

Palantir Technologies is a US software company with longstanding contracts with US defence, law enforcement and intelligence agencies. The company also has extensive UK contracts with the Ministry of Defence, police forces, and other authorities.

In 2023 NHS England awarded Palantir a £330 million contract to build a Federated Data Platform (FDP) on Palantir’s software - a system which aims to integrate NHS data to support clinical decision-making and service planning.

The project has faced criticism from medical organisations including the British Medical Association, which has passed a resolution opposing Palantir’s role in the NHS.

A March 2026 briefing by Medact, supported by Amnesty International and other organisations, outlines the coalition’s concerns and calls for the contract to be terminated.